Highlights DSM-Firmenich

Equities

DSFIR

CH1216478797

Consumer Goods Conglomerates

End-of-day quote Euronext Amsterdam Other stock markets 2025-12-05			5-day change	1st Jan Change
68.68 ^CHF	+1.30%		-2.94%	-29.72%

12-03	DSM-Firmenich Wraps Up EUR1.08 Billion Share Buyback Program Ahead of Schedule	MT
11-30	DSM-Firmenich AG's Equity Buyback announced on February 13, 2025, has closed with 12,930,796 shares, representing 4.89% for ?1,080 million.	CI

Highlights

DSM-Firmenich Wraps Up EUR1.08 Billion Share Buyback Program Ahead of Schedule	12-03	MT
DSM-Firmenich AG's Equity Buyback announced on February 13, 2025, has closed with 12,930,796 shares, representing 4.89% for ?1,080 million.	11-30	CI
Novonesis' quarterly sales beat hopes, shares rise	11-06	RE
DSM-FIRMENICH : From energy to fatigue: DSM-Firmenich's soft Q3	10-30
Dsm-firmenich trims full-year profit outlook on negative FX effects	10-30	RE
Dsm-firmenich Q3 adjusted EBITDA EUR 540 million	10-30	RE
Dsm-firmenich lowers full year outlook on negative FX effects	10-30	RE
AlphaValue/Baader Europe Revises DSM-Firmenich's Price Target Amid 'More Conservative' Outlook	10-22	MT
DSM-FIRMENICH : Adopting a more conservative outlook in updated forecast assumptions	10-20
DSM-Firmenich Revives Talks with Apollo on Sale of Animal Nutrition, Health Unit	09-29	MT
DSM-Firmenich Revives Talks with Apollo on Sale of Animal Nutrition, Health Unit	09-28	MT
Lanxess to Exit Stake in Plastics Joint Venture Envalior	09-23	RE
DSM-Firmenich AG Announces Executive Changes	09-01	CI
Dsm-Firmenich Launches in the U.S., Bringing Relief for Occasional Diarrhea to Children as Young as Six Months	08-14	CI
Lanxess cuts profit guidance as tariffs weigh	08-14	RE
Powell moves to the front line	07-31
DSM-Firmenich AG Reports Earnings Results for the Half Year Ended June 30, 2025	07-31	CI
Dsm-firmenich narrows down profit guidance on FX uncertainty	07-31	RE
DSM-Firmenich Logs Higher H1 Net Profit, Sales	07-31	MT
Dsm-firmenich reports second-quarter core profit above expectations	07-31	RE
Tranche Update on DSM-Firmenich AG's Equity Buyback Plan announced on February 13, 2025.	07-30	CI
Orlando Capital V managed by Orlando Management AG acquired Pentapharm AG and Pentapharm do Brasil Comércio e Exportação Ltda. from DSM-Firmenich AG.	07-24	CI
DSM-Firmenich Expected to Receive Three Final Bids for Animal Feed Unit	07-07	MT
DSM-Firmenich Expected to Receive Three Final Bids for Animal Feed Unit	07-07	MT
DSM-Firmenich Expected to Receive Three Final Bids for Animal Feed Unit	07-07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

DSM-FIRMENICH : From energy to fatigue: DSM-Firmenich's soft Q3

October 30, 2025 at 12:33 pm